# US 2014/0348872 A1 · Compositions and methods for establishing and/or maintaining pregnancy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0348872 A1
- Document ID: US20140348872A1
- Status: Published application
- Kind: A1
- Application number: 14/456,718
- Filed: 2014-08-11
- Published: 2014-11-27
- Earliest claimed: 2007-05-18
- Assignees: Alltech, Inc.
- Applicants: Alltech, Inc.
- Inventors: Thomas P. Lyons; Ronan Power
- Web page: https://patentgrep.com/patent/US20140348872A1

## CPC

- A61K 36/064: Saccharomycetales, e.g. baker's yeast
- A61K 33/04: Sulfur, selenium or tellurium; Compounds thereof
- A61K 36/06: Fungi, e.g. yeasts
- A61P 15/00: Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives
- A61K 48/00: Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to compositions comprising selenium (e.g., organic selenium (e.g., selenized yeast (e.g., SEL-PLEX))) and methods of using the same (e.g., as a therapeutic and/or prophylactic treatment). For example, the present invention provides compositions comprising selenium (e.g., organic selenium (e.g., selenized yeast (e.g., SEL-PLEX))) and methods of using the same for treating and/or preventing one or more conditions (e.g., problems) disorders, and/or diseases related to establishing and/or maintaining a pregnancy. Compositions and methods of the present invention find use in, among other things, research and clinical (e.g., preventative and therapeutic) applications.

## Claims

### Claim 1

A method of altering expression of one or more genes associated with establishment of and/or maintenance of pregnancy in a subject comprising:
administering an effective amount of a composition comprising a dried, nonviable selenium-enriched yeast to the subject wherein the effective amount enhances the expression of one or more genes associated with establishment of and/or maintenance of pregnancy in the subject compared to a control subject.

### Claim 2 (depends on 1)

The method of claim 1, wherein the control subject is not administered selenium.

### Claim 3 (depends on 1)

The method of claim 1, wherein the control subject is administered a composition comprising selenium, wherein the selenium is not present in a dried, nonviable selenium enriched yeast.

### Claim 4 (depends on 1)

The method of claim 1, wherein the one or more genes associated with establishment of and/or maintenance of pregnancy is serum and glucocorticoid inducible-protein kinase (sgk).

### Claim 5 (depends on 1)

The method of claim 1, wherein enhancing expression of one or more genes associated with establishment of and/or maintenance of pregnancy reduces and/or eliminates the risk of perinatal morbidity and/or mortality in the subject.

### Claim 6 (depends on 1)

The method of claim 1, wherein enhancing expression of one or more genes associated with establishment of and/or maintenance of pregnancy increases fetal growth in the subject.

### Claim 7 (depends on 7)

The method of claim 7, wherein increasing fetal growth in said subject comprises increasing fetal growth rate in said subject.

### Claim 8 (depends on 1)

The method of claim 1, wherein enhancing expression of one or more genes associated with establishment of and/or maintenance of pregnancy increases the duration of gestation in said subject.

### Claim 9 (depends on 1)

The method of claim 1, wherein enhancing expression of one or more genes associated with establishment of and/or maintenance of pregnancy promotes the health of the uterus.

### Claim 10 (depends on 10)

The method of claim 10, wherein promoting the health of the uterus comprises promoting connective tissue formation and/or rearrangement.

### Claim 11 (depends on 1)

The method of claim 1, wherein enhancing expression of one or more genes associated with establishment of and/or maintenance of pregnancy promotes proper formation of the pubis.

### Claim 12 (depends on 1)

The method of claim 1, wherein enhancing expression of one or more genes associated with establishment of and/or maintenance of pregnancy promotes the health of the embryo and/or fetus in said subject.

### Claim 13 (depends on 13)

The method of claim 13, wherein promoting the health of the embryo and/or fetus in said subject comprises promoting limb and nervous system development.

### Claim 14 (depends on 13)

The method of claim 13, wherein promoting the health of the embryo and/or fetus in said subject comprises promoting muscle growth and differentiation.

### Claim 15 (depends on 13)

The method of claim 13, wherein promoting the health of the embryo and/or fetus in said subject comprises promoting neural tube development.

### Claim 16 (depends on 13)

The method of claim 13, wherein enhancing expression of one or more genes associated with establishment of and/or maintenance of pregnancy reduces the risk of and/or incidence of an event selected from the group consisting of spontaneous abortion, miscarriage, and birthing complications.

### Claim 17 (depends on 1)

The method of claim 1, wherein the subject is a human.

### Claim 18 (depends on 1)

The method of claim 1, wherein the subject is a non-human mammal.

### Claim 19 (depends on 1)

The method of claim 1, wherein the subject is selected from the group consisting of a subject from an avian species and a subject from an aquatic species.

### Claim 20 (depends on 1)

The method of claim 1, wherein said expression is enhanced two fold or greater in said subject compared to the control subject.

### Claim 21 (depends on 1)

The method of claim 1, wherein said composition comprising selenium is administered in such a way so as to provide between 100 and 400 μg of selenium to said subject each day.

### Claim 22 (depends on 1)

The method of claim 1, wherein said subject is administered said composition for a period of no less than 6 months prior to establishing and/or attempting to establishing a pregnancy.

### Claim 23 (depends on 1)

The method of claim 1, wherein said subject is administered said composition during pregnancy.

### Claim 24 (depends on 1)

The method of claim 1, wherein said one or more genes associated with establishment of and/or maintenance of pregnancy in a subject are selected from the group consisting fibroblast growth factor 2 (FGF2), SNF1-like kinase, platelet-derived growth factor alpha (PDFGA), cyclin D1 (CCND1), activin A receptor type 1 (ACVR1), Sp3 transcription factor (SP3), homeobox A7, homeobox D12, retinoic acid receptor beta (RARB), insulin-like growth factor binding protein 7, and Protein Kinase A.
